Every SEC Form 3/4/5 on record for this filer (CIK 1300997) — 2 issuers, 31 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| VCEL | Vericel Corp | Director | 2015-08-28 → 2026-05-13 | 21 | −$3M |
| OCAT | Ocata Therapeutics, Inc. | President and CEO · Director · lapsed | 2015-07-31 → 2016-02-11 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| VCEL | 2026-05-11 | Sell | 2,500 | $33.05 | $82,625 | 26,302 |
| VCEL | 2026-05-11 | Sell | 7,500 | $32.64 | $244,800 | 18,802 |
| VCEL | 2025-12-03 | Sell | 2,500 | $37.83 | $94,575 | 25,602 |
| VCEL | 2025-12-02 | Sell | 2,500 | $37.97 | $94,925 | 28,102 |
| VCEL | 2024-12-04 | Sell | 2,600 | $58.72 | $152,672 | 27,402 |
| VCEL | 2023-12-14 | Sell | 5,000 | $37.31 | $186,550 | 26,802 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.
